David Woodhouse
Förmögenhet: 51 994 $ per 2026-07-31
Förmögenhet: 51 994 $ per 2026-07-31
David J.
Woodhouse is currently Chief Executive Officer & Director at Nuvig Therapeutics, Inc. since 2025.
He is Chairman at Surrozen, Inc. since 2023 and Director at Surrozen Operating, Inc. since 2020.
Formerly, Dr. Woodhouse was Managing Director at Goldman Sachs & Co. LLC from 2002 to 2015.
He was Chief Executive & Financial Officer, Director at NGM Biopharmaceuticals, Inc. from 2018 to 2020.
He also worked as a Research Assistant at Amgen, Inc. Education includes undergraduate studies at the University of California, Santa Barbara, an MBA from Tuck School of Business at Dartmouth, and a doctorate from Stanford University School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SURROZEN INC 0,02 % | 2026-05-13 | 2 341 ( 0,02 % ) | 51 994 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| SURROZEN, INC. | Ordförande | 2023-04-01 |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Direktör/Styrelseledamot | 2020-09-25 |
Nuvig Therapeutics, Inc.
Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Verkställande Direktör | 2025-09-09 |
| Företag | Position | Slut |
|---|---|---|
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Företagsledare/Principal | 2015-01-01 |
| AMGEN INC. | Företagsledare/Principal | - |
| NGM BIOPHARMACEUTICALS, INC. | Verkställande Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
NGM Biopharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Surrozen, Inc.
Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
Nuvig Therapeutics, Inc.
Nuvig Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops translating novel therapeutics medicine for autoimmune diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån